Jennifer M. Spangle

1.5k total citations
24 papers, 809 citations indexed

About

Jennifer M. Spangle is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jennifer M. Spangle has authored 24 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Jennifer M. Spangle's work include Epigenetics and DNA Methylation (9 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Jennifer M. Spangle is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Jennifer M. Spangle collaborates with scholars based in United States, India and Ireland. Jennifer M. Spangle's co-authors include Karl Münger, Thomas M. Roberts, Jean J. Zhao, Jordan M. Meyers, Hailing Cheng, Carolynn E. Ohlson, Lewis C. Cantley, Lauren M. Thorpe, Koen M.A. Dreijerink and Charles Y. Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jennifer M. Spangle

23 papers receiving 802 citations

Peers

Countries citing papers authored by Jennifer M. Spangle

Since Specialization

Citations

This map shows the geographic impact of Jennifer M. Spangle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M. Spangle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M. Spangle more than expected).

Fields of papers citing papers by Jennifer M. Spangle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer M. Spangle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M. Spangle. The network helps show where Jennifer M. Spangle may publish in the future.

Co-authorship network of co-authors of Jennifer M. Spangle

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M. Spangle. A scholar is included among the top collaborators of Jennifer M. Spangle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M. Spangle. Jennifer M. Spangle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic In Vivo Mapping of the Methylproteome Using a Chemoenzymatic Approach 2025 ·Journal of the American Chemical Society ·(unknown), (unknown), (unknown), (unknown), (unknown), Christian M. Beusch, Robert B. Jones, (unknown), (unknown), (unknown), (unknown), (unknown), Pritha Bagchi, Roger B. Deal, David J. Katz, Anita H. Corbett, David E. Gordon, Monika Raj, Jennifer M. Spangle	0
2	Histone H3E50K remodels chromatin to confer oncogenic activity and support an EMT phenotype 2025 ·NAR Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), C. Christina Mehta, (unknown), Milo B. Fasken, Andrew L. Hong, Steven A. Sloan, Anita H. Corbett, Jennifer M. Spangle	2
3	Tunable fluorescent probes for detecting aldehydes in living systems 2024 ·Chemical Science ·(unknown), (unknown), (unknown), (unknown), (unknown), Jennifer M. Spangle, Adam D. Gracz, (unknown)	13
4	Chemical sensors for imaging total cellular aliphatic aldehydes in live cells 2023 ·Chemical Science ·(unknown), (unknown), (unknown), Sophia Allaf Shahin, Jennifer M. Spangle, Monika Raj	9
5	Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response 2023 ·Cancers ·(unknown), (unknown), (unknown), Jennifer M. Spangle	13
6	Identification of ligand–receptor pairs that drive human astrocyte development 2023 ·Nature Neuroscience ·(unknown), (unknown), Maureen M. Sampson, (unknown), (unknown), (unknown), (unknown), Tarun N. Bhatia, Jennifer M. Spangle, Steven A. Sloan	22
7	Exploring the Molecular Underpinnings of Cancer-Causing Oncohistone Mutants Using Yeast as a Model 2023 ·Journal of Fungi ·(unknown), (unknown), Jennifer M. Spangle, Anita H. Corbett, (unknown)	5
8	A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations 2022 ·G3 Genes Genomes Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Milo B. Fasken, Jennifer M. Spangle, Anita H. Corbett	5
9	Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor–positive Breast Cancer 2022 ·Cancer Research Communications ·Robert B. Jones, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrew L. Hong, Jennifer M. Spangle	6
10	Medulloblastoma and the DNA Damage Response 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Dolores Hambardzumyan, Tobey J. MacDonald, Jennifer M. Spangle, Anna Marie Kenney	1
11	Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs 2022 ·Frontiers in Cell and Developmental Biology ·Mi-Young Lee, (unknown), (unknown), Jeremy M. Boss, Christopher D. Scharer, Jennifer M. Spangle, Karmella A. Haynes, Curtis J. Henry	3
12	Practical advice for mentoring and supporting faculty colleagues in STEM fields: Views from mentor and mentee perspectives 2021 ·Journal of Biological Chemistry ·Jennifer M. Spangle, Homa Ghalei, Anita H. Corbett	3
13	PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α 2017 ·Proceedings of the National Academy of Sciences ·Lauren M. Thorpe, Jennifer M. Spangle, Carolynn E. Ohlson, Hailing Cheng, Thomas M. Roberts, Lewis C. Cantley, Jean J. Zhao	81
14	Epigenetic regulation of RTK signaling 2017 ·Journal of Molecular Medicine ·Jennifer M. Spangle, Thomas M. Roberts	20
15	The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer 2017 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Jennifer M. Spangle, Thomas M. Roberts, Jean J. Zhao	137
16	PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer 2016 ·Cell Reports ·Jennifer M. Spangle, Koen M.A. Dreijerink, Anna C. Groner, Hailing Cheng, Carolynn E. Ohlson, Jaime M. Reyes, Charles Y. Lin, James E. Bradner, Jean J. Zhao, Thomas M. Roberts, Myles Brown	86
17	PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers 2015 ·Oncogene ·Qīng Wáng, (unknown), Jennifer M. Spangle, Thanh Von, Thomas M. Roberts, Nancy U. Lin, Ian E. Krop, Eric P. Winer, Jean J. Zhao	35
18	The Human Papillomavirus Type 8 E6 Protein Interferes with NOTCH Activation during Keratinocyte Differentiation 2013 ·Journal of Virology ·Jordan M. Meyers, Jennifer M. Spangle, Karl Münger	79
19	The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor Species 2013 ·PLoS Pathogens ·Jennifer M. Spangle, Karl Münger	66
20	Expression of a viral oncoprotein in normal human epithelial cells triggers an autophagy-related process: Is autophagy an “Achilles’ heel” of human cancers? 2009 ·Autophagy ·Xiaobo Zhou, Jennifer M. Spangle, Karl Münger	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact